ImmPACT Bio | LinkedIn (original) (raw)

Biotechnology Research

West Hills, California 8,044 followers

We are developing advanced therapies for cancer patients with critical unmet needs

View all 108 employees

About us

ImmPACT Bio is now part of Lyell Immunopharma. Learn how we are continuing to advance next-generation cell therapies that offer patients improved outcomes @Lyell or www.lyell.com. About ImmPACT Bio: ImmPACT Bio USA, Inc., is a clinical-stage company dedicated to the discovery of transformative chimeric antigen receptor (CAR) T-cell therapies that address key biological challenges in treating cancer and autoimmune diseases. Our technology is designed to precisely distinguish cancer and diseased cells from normal cells; thereby eliminating them without damaging normal tissues. The company was founded in 2017 in the FuturRx incubator (Israel). In 2019, ImmPACT Bio was incorporated in the US. In 2021 ImmPACT Bio merged with Kalthera. In 2022 we moved our Corporate offices to West Hills, CA and built a state-of-the-art clinical manufacturing facility.

Industry

Biotechnology Research

Company size

51-200 employees

Headquarters

West Hills, California

Type

Public Company

Founded

2017

Specialties

CAR-T, Immunotherapy, Cancer Therapy, On target off tumor toxicity , Selective treatment , Logic gate, Oncology, Biotechnology, Research, Immunotherapy, autoimmune, and lupus

Locations

Employees at ImmPACT Bio

Updates

ImmPACT Bio reposted this
We’re honored to be recognized as one of the BioSpace - Best Places to Work in 2025! A huge thank you to our dedicated team whose hard work makes this possible. It’s your passion that builds the vibrant, supportive culture we’re so proud of. #BestPlacestoWork #ThankYouTeam
We’re honored to be recognized as one of the BioSpace - Best Places to Work in 2025! A huge thank you to our dedicated team whose hard work makes this possible. It’s your passion that builds the vibrant, supportive culture we’re so proud of. #BestPlacestoWork #ThankYouTeam
We’re thrilled to announce that we’re now part of Lyell Immunopharma! Partnering with such a visionary team, dedicated to pushing the boundaries of cell therapy, marks an exciting new chapter in our journey. Together, we’re committed to accelerating access to breakthrough therapies for patients who need them most. #celltherapy #CART https://lyell.com/
Thrilled to announce that Lyell Immunopharma entered into a definitive agreement to acquire ImmPACT Bio! The combination will bring together a world-class Team and a pipeline of next-generation CAR T-cell therapies. Our first clinical data readout from IMPT-314’s ongoing Phase 1/2 study will be presented at a major medical conference later this year. “I am incredibly proud of the ImmPACT team and all of their accomplishments in developing next-generation CAR T-cell therapies,” stated Sumant Ramachandra, M.D., Ph.D., Chief Executive Officer of ImmPACT. “This transaction validates our novel science and enhances the potential for this therapy to make a meaningful impact on patients' lives. I am confident that in Lyell, we have found a team that shares our passion for advancing novel science to benefit patients.” Thank you to our employees, leadership team, collaborators, scientific and clinical partners, Founders, investors, Board of Directors, and many more people for the support as we built ImmPACT Bio from its academic roots to a company with several open INDs, ongoing clinical programs and a robust pipeline of next-generation CAR T-cell therapies. Read more here:https://lnkd.in/gy2dT-ta #CARTCellTherapy #NextGenerationTherapies #Biotechnology #MakeAnImmPACT
We stand with the fighters, celebrate the survivors, and honor the memory of those we've lost to this disease. Together, we raise awareness and push forward in the fight against breast cancer. Early detection and continued innovation in treatments make all the difference. Let’s keep working towards a future where breast cancer is a thing of the past.#BreastCancerAwareness #TogetherWeFight #ImmPACTBio
ImmPACT Bio is pleased to announce that we will participate at the 2024 Cell and Gene Meeting on the Mesa, to be held October 7-9, 2024 in Phoenix, AZ.#cartcelltherapy, #CGMesa24, #MakeAnImmPACT
On this September 11, we pause to honor the memory of those we lost and express our gratitude to the heroes who emerged in the face of unimaginable tragedy. It's a reminder of the resilience, unity, and compassion that can arise in the darkest of times. #NeverForget #September11 #Resilience

Join now to see what you are missing

Join now

ImmPACT Bio | LinkedIn (original) (raw)

Biotechnology Research

West Hills, California 8,044 followers

We are developing advanced therapies for cancer patients with critical unmet needs

About us

Locations

Employees at ImmPACT Bio

Updates

Join now to see what you are missing

Similar pages

Browse jobs